Previous Close | 3.2000 |
Open | 3.2300 |
Bid | 3.1300 x 800 |
Ask | 3.2500 x 1100 |
Day's Range | 3.1233 - 3.2955 |
52 Week Range | 2.6800 - 8.6200 |
Volume | |
Avg. Volume | 67,456 |
Market Cap | 22.411M |
Beta (5Y Monthly) | 1.67 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.4760 |
Earnings Date | Mar 08, 2022 - Mar 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, May 17, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the first quarter ended March 31, 2022 and provided an update on recent corporate developments. “Throughout the first quarter, we continued to advance our missi
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Tuesday, May 17, 2022 at 8:30 a.m. ET to report financial results for the first quarter ended March 31, 2022 and to provide a business overview. To access the live conference ca